Hypertension, Vol 8, 323-331, Copyright © 1986 by American Heart Association
DD Smyth, S Umemura and WA Pettinger
Renal nerve stimulation-induced antinatriuresis normally is mediated
through post-synaptic alpha 1-adrenergic receptors; however, prazosin-
induced alpha 1-adrenergic receptor blockade is associated clinically with
sodium retention and not natriuresis. To study whether alpha 2- adrenergic
receptors mediate renal nerve stimulation-induced antinatriuresis after
chronic prazosin treatment, Sprague-Dawley rats were pretreated for 3 days
with prazosin (3 mg/kg/day i.p. plus 0.15 mg/ml drinking water) or vehicle
(untreated). In isolated perfused (Krebs-Henseleit; Ficoll, 3.5 g/dl, +
albumin, 1.0 g/dl at 36 degrees C) kidneys from untreated rats, subpressor
levels of renal nerve stimulation (approximately 1 Hz, 10 V, 1 msec)
decreased (p less than 0.05) sodium (from 4.50 +/- 0.42 to 1.71 +/- .23
muEq/min) and urinary excretion rate (from 87.2 +/- 4.1 to 57.9 +/- 3.9
microliter/min). Adding prazosin (30 nM) to the perfusate completely
(approximately 90%) reversed this effect (p less than 0.05), while alpha
2-adrenergic receptor blockade with yohimbine (300 nM) had no effect. In
perfused kidneys from prazosin-treated rats, renal nerve stimulation
decreased (p less than 0.05) sodium (from 3.24 +/- .40 to 1.32 +/- .27
muEq/min) and urinary excretion rate (from 78.7 +/- 5.0 to 54.1 +/- 5.3
microliter/min). However, adding prazosin (100 nM) to the perfusate
produced only a slight, insignificant reversal of these effects; prazosin
plus yohimbine were required to completely reverse the effects. These
results suggest that renal nerve stimulation-induced sodium reabsorption
was activated by alpha 1-adrenergic receptors in untreated rats and in part
by alpha 2-adrenergic receptors in rats pretreated for 3 days with
prazosin.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Renal alpha 2-adrenergic receptors multiply and mediate sodium retention after prazosin treatment
This article has been cited by other articles:
![]() |
F. A. Gesek {alpha}1- and {alpha}2-Adrenoceptor Control of Sodium Transport Reverses in Developing Hypertension Hypertension, January 1, 1999; 33(1): 524 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Wilborn, D. Sun, and J. A. Schafer Expression of multiple alpha -adrenoceptor isoforms in rat CCD Am J Physiol Renal Physiol, July 1, 1998; 275(1): F111 - F118. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Townsend and O. B. Holland Combination of Converting Enzyme Inhibitor With Diuretic for the Treatment of Hypertension Arch Intern Med, June 1, 1990; 150(6): 1175 - 1183. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |